Chong Kun Dang Pharmaceutical Corp. logo

Chong Kun Dang Pharmaceutical Corp.

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Chong Kun Dang Pharmaceutical Corp. is a Pharmaceutical company.

Investor Profile

Chong Kun Dang Pharmaceutical Corp. has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chong Kun Dang Pharmaceutical Corp. frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Consensus Business Group
Europe, England, United Kingdom, London
Co-Investments: 1
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 1
RM Global Partners
North America, New York, United States, New York
Co-Investments: 1
SBI Japan-Israel Innovation Fund
Asia, Tel Aviv, Israel, Tel Aviv-yafo
Co-Investments: 1
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
KB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Handok
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 1

What are some of recent deals done by Chong Kun Dang Pharmaceutical Corp.?

BIOMx

Ness Ziona, HaMerkaz, Israel

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

BiotechnologyHealth CareTherapeutics
Series BFeb 20, 2019
Amount Raised: $32,000,000